CareDx CEO Reg Seeto to Present at AAKP 4th Annual Policy Summit
Reg Seeto, President and CEO of CareDx (Nasdaq: CDNA), will discuss telehealth innovations for transplant patient care at the AAKP 2021 Summit on June 17, 2021. The presentation, titled Improving Access to Transplant Care, highlights solutions like RemoTraC, AlloCare, and Tx Connect, which have become essential, especially during the COVID-19 pandemic. Seeto emphasizes that such technologies enhance patient access and care throughout the transplant journey. AAKP advocates for patient-centered innovations in the kidney care community.
- None.
- None.
Reg Seeto will present on technology that enables transplant patient care at the AAKP 2021 Summit
SOUTH SAN FRANCISCO, Calif., June 17, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced that Reg Seeto, President and CEO of CareDx, will present "Improving Access to Transplant Care: Telehealth & Technology to Enable Patients Along the Transplant Journey," at the American Association of Kidney Patients (AAKP) 4th Annual Policy Summit, which will be held virtually on June 17, 2021.
Reg Seeto will be presenting on the growing need for telehealth solutions, accelerated by the COVID-19 pandemic, that has led to innovative solutions like RemoTraC, an at-home blood draw service, AlloCare, a transplant specific patient care app to empower patients to better manage their overall care, and Tx Connect, a cloud-based solution that helps more patients being placed on the referral list for transplant.
"Telehealth has proven to be critically important for transplant patients over the past year, especially with the added risk of COVID-19," said Reg Seeto, President and CEO, CareDx. "At CareDx, we continue to drive new technologies that improve access to care throughout the patient journey."
"As a matter of principle, AAKP is a staunch advocate for kidney patient consumer care choice of, and access to, innovations for the timely diagnosis and treatment of kidney diseases, including those delivered by telemedicine," states Richard Knight, president of AAKP and kidney transplant recipient. "As the premier kidney patient organization in America, with the largest membership of kidney transplant patients, AAKP has carefully analyzed the impact of COVID-19 on the patient community and believes telemedicine and key medical innovations, such as those provided by CareDx, Inc., have set a new standard of care for patient-centered medicine. We are honored to have CareDx CEO Reginald Seeto as a presenter at our National Policy Summit and appreciate the support CareDx has provided since our 2018 Inaugural Summit."
To learn more about AAKP's Fourth Annual Policy Summit, visit https://aakp.org/programs-and-events/public-policy-summit/
About CareDx
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.
CONTACTS:
CareDx, Inc.
Sasha King
Chief Marketing Officer
415-287-2393
sking@caredx.com
Investor Relations
Greg Chodaczek
347-610-7010
investor@caredx.com
FAQ
What will Reg Seeto discuss at the AAKP 2021 Summit?
When is the AAKP 2021 Summit taking place?
What are some technologies mentioned in CareDx's presentation?
How has COVID-19 influenced telehealth for transplant patients?
What is CareDx's focus in healthcare?
